NYSE:HUMHealthcare
Humana (HUM) Valuation Check As New Cancer Care Alliance Targets Medicare Advantage Growth
Humana (HUM) shares are in focus after the company announced a new partnership with Atlas Oncology Partners to roll out a coordinated cancer care model for Medicare Advantage members.
See our latest analysis for Humana.
The new cancer care partnership comes as Humana’s share price shows a 9.99% 1 month share price return and a 7.36% year to date share price return. At the same time, the 3 year total shareholder return of a 40.33% decline highlights longer term pressure, suggesting recent...